The field of diabetes treatment has seen a surge in innovation with the emergence of novel GLP-1 receptor agonists. Among these, retatrutide and trizepatide are rapidly emerging as potential game-changers. These of https://deaconqtxv083965.actoblog.com/39788727/new-glp-1-receptor-agonists-retatrutide-and-trizepatide